炎症或心血管疾病血液生物标志物的纵向升高与静脉血栓栓塞症发生率的关系
基于ARIC前瞻性队列9844名参与者,测量1990-1992年至1996-1998年间CRP、NT-proBNP和肌钙蛋白T的6年变化,随访至2015年(中位17.6年)。NT-proBNP从<100 pg/mL升至≥100 pg/mL者VTE风险增加(HR 1.44,95%CI 1.15-1.80),CRP和肌钙蛋白T变化与VTE无显著关联。
要点
- NT-proBNP 6年升高与后续VTE风险增加显著相关,CRP和肌钙蛋白T变化无显著关联。
- NT-proBNP从<100 pg/mL升至≥100 pg/mL者VTE的HR为1.44(95%CI 1.15-1.80)。
- 调整冠心病、心衰和房颤后NT-proBNP与VTE关联减弱(HR 1.24,95%CI 0.99-1.56)。
核心结论
- NT-proBNP水平6年升高与VTE发生率增加显著相关,而CRP和肌钙蛋白T的变化无显著关联。
- 作者认为最可能的解释是NT-proBNP升高反映亚临床容量负荷增加和静脉淤滞或未被识别的亚临床肺栓塞,或是即将发生心脏病的风险标志。
研究设计与样本
- 前瞻性队列研究,基于人群的ARIC队列9844名参与者,测量1990-1992年至1996-1998年间CRP、NT-proBNP和肌钙蛋白T的6年变化,随访VTE至2015年,中位随访17.6年。
主要发现
- NT-proBNP从<100 pg/mL升至≥100 pg/mL者较两次均<100 pg/mL的参照组VTE风险增加,HR 1.44(95%CI 1.15-1.80)。
- 随访前10年内该HR为1.66(95%CI 1.19-2.31),调整 prevalent 和 incident 冠心病、心衰和房颤后减弱为1.24(95%CI 0.99-1.56)。
- CRP和肌钙蛋白T的6年变化与VTE发生率无显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Inflammatory and cardiac diseases are associated with increased venous thromboembolism (VTE) risk. Our prospective study assessed rise in inflammatory or cardiac biomarkers and VTE risk. A greater 6-year rise in N-terminal natriuretic peptide is associated with increased VTE incidence. Volume overload or impending cardiac disease may contribute to VTE occurrence. SUMMARY: Background We previously showed that participants in the population-based Atherosclerosis Risk in Communities (ARIC) cohort with elevated levels of blood biomarkers of inflammation or cardiac disease were at increased risk of venous thromboembolism (VTE). Objective We hypothesized that ARIC participants with larger 6-year increases in the levels of three biomarkers - C-reactive protein (CRP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and troponin T - would also have an increased subsequent risk of VTE. Methods We measured changes in the levels of these biomarkers in 9844 participants from 1990-1992 to 1996-1998, and then identified VTEs through 2015. Results A greater 6-year rise in the level of NT-proBNP, but not in that of CRP or troponin T, was significantly associated with increased VTE incidence over a median of 17.6 years of follow-up. After adjustment for other VTE risk factors, those whose NT-proBNP level rose from < 100 pg mL-1 to ≥ 100 pg mL-1 had a hazard ratio for VTE of 1.44 (95% confidence interval [CI] 1.15-1.80), as compared with the reference group with an NT-proBNP level of < 100 pg mL-1 at both times. This hazard ratio was slightly higher (1.66, 95% CI 1.19-2.31) during the first 10 years of follow-up, but was attenuated (1.24, 95% CI 0.99-1.56) after adjustment for prevalent and incident coronary heart disease, heart failure, and atrial fibrillation. Conclusions The two most likely explanations for our results are that: (i) an increasing NT-proBNP level reflects increasing subclinical volume overload and potentially increased venous stasis or subclinical PE that had gone unrecognized over time; or (ii) an increasing NT-proBNP level is a risk marker for impending cardiac disease that places patients at risk of VTE.
引用
- Folsom AR, Lutsey PL, Heckbert SR, et al. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism. J Thromb Haemost. 2018. PMID: 30007116. doi:10.1111/jth.14241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。